1-2 of 2
Kristy R. Bodden
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-Term Follow up of a Phase II Study of Guadecitabine (SGI-110) in Patients with Higher-Risk Myelodysplastic Syndrome (MDS)

Free
Kiyomi Morita, MDPhD, Guillermo Montalban Bravo, MD, Koji Sasaki, MD, Kristy R. Bodden, Feng Wang, PhD, Prithviraj Bose, MD, Yesid Alvarado, MD, Naval Daver, MD, Gautam Borthakur, MD, Farhad Ravandi, MBBS, Koichi Takahashi, MD PhD, Elias Jabbour, MD, Courtney D. DiNardo, MD MSCE, Naveen Pemmaraju, MD, Tapan M. Kadia, MD, Maro Ohanian, DO, Sherry A. Pierce, BSN, BA, Mohammad Azab, MD MSc, MBA, Hagop M. Kantarjian, MD, Guillermo Garcia-Manero, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 21–22.
https://doi.org/10.1182/blood-2020-140614
Published: 2020
Journal Articles

Final Report of a Phase II Study of Guadecitabine (SGI-110) in Patients (pts) with Previously Untreated Myelodysplastic Syndrome (MDS)

Free
Guillermo Garcia-Manero, MD, Koji Sasaki, MD, Guillermo Montalban-Bravo, MD, Kristy R. Bodden, Prithviraj Bose, MD, Yesid Alvarado, MD, Naval G. Daver, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Koichi Takahashi, MD, Jorge E. Cortes, MD, Elias J. Jabbour, MD, Kiran Naqvi, MDMPH, Courtney D. DiNardo, MDMSc, Christopher B. Benton, MD, Naveen Pemmaraju, MD, Tapan M. Kadia, MD, Maro N. Ohanian, DO, Sherry A. Pierce, BSN, BA, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 232.
https://doi.org/10.1182/blood-2018-99-116838
Published: 2018